Breast density estimation is an important part of breast cancer risk assessment, as mammographic density is associated with risk. However, density assessed by multiple experts can be subject to high inter-observer variability, so automated methods are increasingly used. We investigate the inter-reader variability and risk prediction for expert assessors and a deep learning approach. Screening data from a cohort of 1328 women, case-control matched, was used to compare between two expert readers and between a single reader and a deep learning model, Manchester artificial intelligence - visual analog scale (MAI-VAS). Bland-Altman analysis was used to assess the variability and matched concordance index to assess risk. Although the mean differences for the two experiments were alike, the limits of agreement between MAI-VAS and a single reader are substantially lower at +SD (standard deviation) 21 (95% CI: 19.65, 21.69) -SD 22 (95% CI: <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo> <mn>22.71</mn></mrow> </math> , <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo> <mn>20.68</mn></mrow> </math> ) than between two expert readers +SD 31 (95% CI: 32.08, 29.23) -SD 29 (95% CI: <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo> <mn>29.94</mn></mrow> </math> , <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo> <mn>27.09</mn></mrow> </math> ). In addition, breast cancer risk discrimination for the deep learning method and density readings from a single expert was similar, with a matched concordance of 0.628 (95% CI: 0.598, 0.658) and 0.624 (95% CI: 0.595, 0.654), respectively. The automatic method had a similar inter-view agreement to experts and maintained consistency across density quartiles. The artificial intelligence breast density assessment tool MAI-VAS has a better inter-observer agreement with a randomly selected expert reader than that between two expert readers. Deep learning-based density methods provide consistent density scores without compromising on breast cancer risk discrimination.

Breast cancer may persist within milk ducts (ductal carcinoma <i>in situ</i>, DCIS) or advance into surrounding breast tissue (invasive ductal carcinoma, IDC). Occasionally, invasiveness in cancer may be underestimated during biopsy, leading to adjustments in the treatment plan based on unexpected surgical findings. Artificial intelligence/computer-aided diagnosis (AI/CADx) techniques in medical imaging may have the potential to predict whether a lesion is purely DCIS or exhibits a mixture of IDC and DCIS components, serving as a valuable supplement to biopsy findings. To enhance the evaluation of AI/CADx performance, assessing variability on a lesion-by-lesion basis via likelihood assurance measures could add value. We evaluated the performance in the task of distinguishing between pure DCIS and mixed IDC/DCIS breast cancers using computer-extracted radiomic features from dynamic contrast-enhanced magnetic resonance imaging using 0.632+ bootstrapping methods (2000 folds) on 550 lesions (135 pure DCIS, 415 mixed IDC/DCIS). Lesion-based likelihood assurance was measured using a sureness metric based on the 95% confidence interval of the classifier output for each lesion. The median and 95% CI of the 0.632+-corrected area under the receiver operating characteristic curve for the task of classifying lesions as pure DCIS or mixed IDC/DCIS were 0.81 [0.75, 0.86]. The sureness metric varied across the dataset with a range of 0.0002 (low sureness) to 0.96 (high sureness), with combinations of high and low classifier output and high and low sureness for some lesions. Sureness metrics can provide additional insights into the ability of CADx algorithms to pre-operatively predict whether a lesion is invasive.

We examine the transformative potential of artificial intelligence (AI) in medical imaging diagnosis, focusing on improving diagnostic accuracy and efficiency through advanced algorithms. It addresses the significant challenges preventing immediate clinical adoption of AI, specifically from technical, ethical, and legal perspectives. The aim is to highlight the current state of AI in medical imaging and outline the necessary steps to ensure safe, effective, and ethically sound clinical implementation. We conduct a comprehensive discussion, with special emphasis on the technical requirements for robust AI models, the ethical frameworks needed for responsible deployment, and the legal implications, including data privacy and regulatory compliance. Explainable artificial intelligence (XAI) is examined as a means to increase transparency and build trust among healthcare professionals and patients. The analysis reveals key challenges to AI integration in clinical settings, including the need for extensive high-quality datasets, model reliability, advanced infrastructure, and compliance with regulatory standards. The lack of explainability in AI outputs remains a barrier, with XAI identified as crucial for meeting transparency standards and enhancing trust among end users. Overcoming these barriers requires a collaborative, multidisciplinary approach to integrate AI into clinical practice responsibly. Addressing technical, ethical, and legal issues will support a softer transition, fostering a more accurate, efficient, and patient-centered healthcare system where AI augments traditional medical practices.

The accurate assessment of computed tomography (CT) image quality is crucial for ensuring diagnostic reliability while minimizing radiation dose. Radiologists' evaluations are time-consuming and labor-intensive. Existing automated approaches often require large CT datasets with predefined image quality assessment (IQA) scores, which often do not align well with clinical evaluations. We aim to develop a reference-free, automated method for CT IQA that closely reflects radiologists' evaluations, reducing the dependency on large annotated datasets. We propose Task-Focused Knowledge Transfer (TFKT), a deep learning-based IQA method leveraging knowledge transfer from task-similar natural image datasets. TFKT incorporates a hybrid convolutional neural network-transformer model, enabling accurate quality predictions by learning from natural image distortions with human-annotated mean opinion scores. The model is pre-trained on natural image datasets and fine-tuned on low-dose computed tomography perceptual image quality assessment data to ensure task-specific adaptability. Extensive evaluations demonstrate that the proposed TFKT method effectively predicts IQA scores aligned with radiologists' assessments on in-domain datasets and generalizes well to out-of-domain clinical pediatric CT exams. The model achieves robust performance without requiring high-dose reference images. Our model is capable of assessing the quality of <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>∼</mo> <mn>30</mn></mrow> </math> CT image slices in a second. The proposed TFKT approach provides a scalable, accurate, and reference-free solution for CT IQA. The model bridges the gap between traditional and deep learning-based IQA, offering clinically relevant and computationally efficient assessments applicable to real-world clinical settings.

Four-dimensional (4D) ultrasound imaging is widely used in clinics for diagnostics and therapy guidance. Accurate target tracking in 4D ultrasound is crucial for autonomous therapy guidance systems, such as radiotherapy, where precise tumor localization ensures effective treatment. Supervised deep learning approaches rely on reliable ground truth, making accurate labels essential. We investigate the reliability of expert-labeled ground truth data by evaluating intra- and inter-observer variability in landmark labeling for 4D ultrasound imaging in the liver. Eight 4D liver ultrasound sequences were labeled by eight expert observers, each labeling eight landmarks three times. Intra- and inter-observer variability was quantified, and observer survey and motion analysis were conducted to determine factors influencing labeling accuracy, such as ultrasound artifacts and motion amplitude. The mean intra-observer variability ranged from <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>1.58</mn> <mtext>  </mtext> <mi>mm</mi> <mo>±</mo> <mn>0.90</mn> <mtext>  </mtext> <mi>mm</mi></mrow> </math> to <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>2.05</mn> <mtext>  </mtext> <mi>mm</mi> <mo>±</mo> <mn>1.22</mn> <mtext>  </mtext> <mi>mm</mi></mrow> </math> depending on the observer. The inter-observer variability for the two observer groups was <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>2.68</mn> <mtext>  </mtext> <mi>mm</mi> <mo>±</mo> <mn>1.69</mn> <mtext>  </mtext> <mi>mm</mi></mrow> </math> and <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>3.06</mn> <mtext>  </mtext> <mi>mm</mi> <mo>±</mo> <mn>1.74</mn> <mtext>  </mtext> <mi>mm</mi></mrow> </math> . The observer survey and motion analysis revealed that ultrasound artifacts significantly affected labeling accuracy due to limited landmark visibility, whereas motion amplitude had no measurable effect. Our measured mean landmark motion was <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>11.56</mn> <mtext>  </mtext> <mi>mm</mi> <mo>±</mo> <mn>5.86</mn> <mtext>  </mtext> <mi>mm</mi></mrow> </math> . We highlight variability in expert-labeled ground truth data for 4D ultrasound imaging and identify ultrasound artifacts as a major source of labeling inaccuracies. These findings underscore the importance of addressing observer variability and artifact-related challenges to improve the reliability of ground truth data for evaluating target tracking algorithms in 4D ultrasound applications.

Artificial intelligence (AI) holds significant potential to enhance various aspects of oncology, spanning the cancer care continuum. This review provides an overview of current and emerging AI applications, from risk assessment and early detection to treatment and supportive care. AI-driven tools are being developed to integrate diverse data sources, including multi-omics and electronic health records, to improve cancer risk stratification and personalize prevention strategies. In screening and diagnosis, AI algorithms show promise in augmenting the accuracy and efficiency of medical image analysis and histopathology interpretation. AI also offers opportunities to refine treatment planning, optimize radiation therapy, and personalize systemic therapy selection. Furthermore, AI is explored for its potential to improve survivorship care by tailoring interventions and to enhance end-of-life care through improved symptom management and prognostic modeling. Beyond care delivery, AI augments clinical workflows, streamlines the dissemination of up-to-date evidence, and captures critical patient-reported outcomes for clinical decision support and outcomes assessment. However, the successful integration of AI into clinical practice requires addressing key challenges, including rigorous validation of algorithms, ensuring data privacy and security, and mitigating potential biases. Effective implementation necessitates interdisciplinary collaboration and comprehensive education for health care professionals. The synergistic interaction between AI and clinical expertise is crucial for realizing the potential of AI to contribute to personalized and effective cancer care. This review highlights the current state of AI in oncology and underscores the importance of responsible development and implementation.

We aimed to review the role of functional imaging in cervical cancer to underscore its significance in the diagnosis and management of cervical cancer and in improving patient outcomes. This rapid literature review targeting the clinical guidelines for functional imaging in cervical cancer sourced literature from 2017 to 2023 using PubMed, Google Scholar, MEDLINE and Scopus. Keywords such as cervical cancer, cervical neoplasms, functional imaging, stag*, treatment response, monitor* and New Zealand or NZ were used with Boolean operators to maximise results. Emphasis was on English full research studies pertinent to New Zealand. The study quality of the reviewed articles was assessed using the Joanna Briggs Institute critical appraisal checklists. The search yielded a total of 21 papers after all duplicates and yields that did not meet the inclusion criteria were excluded. Only one paper was found to incorporate the New Zealand context. The papers reviewed yielded results that demonstrate the important role of functional imaging in cervical cancer diagnosis, staging and treatment response monitoring. Techniques such as dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), diffusion-weighted magnetic resonance imaging (DW-MRI), computed tomography perfusion (CTP) and positron emission tomography computed tomography (PET/CT) provide deep insights into tumour behaviour, facilitating personalised care. Integration of artificial intelligence in image analysis promises increased accuracy of these modalities. Functional imaging could play a significant role in a unified approach in New Zealand to improve patient outcomes for cervical cancer management. Therefore, this study advocates for New Zealand's medical sector to harness functional imaging's potential in cervical cancer management.

Ultrasound imaging is critical for clinical diagnostics, providing insights into various diseases and organs. However, artificial intelligence (AI) in this field faces challenges, such as the need for large labeled datasets and limited task-specific model applicability, particularly due to ultrasound's low signal-to-noise ratio (SNR). To overcome these, we introduce the Ultrasound Representation Foundation Model (URFM), designed to learn robust, generalizable representations from unlabeled ultrasound images, enabling label-efficient adaptation to diverse diagnostic tasks. URFM is pre-trained on over 1M images from 15 major anatomical organs using representation-based masked image modeling (MIM), an advanced self-supervised learning. Unlike traditional pixel-based MIM, URFM integrates high-level representations from BiomedCLIP, a specialized medical vision-language model, to address the low SNR issue. Extensive evaluation shows that URFM outperforms state-of-the-art methods, offering enhanced generalization, label efficiency, and training-time efficiency. URFM's scalability and flexibility signal a significant advancement in diagnostic accuracy and clinical workflow optimization in ultrasound imaging.

Retrospective study. The study aimed to develop and authenticated a deep learning model based on X-ray images to accurately diagnose fresh thoracolumbar vertebral compression fractures. In clinical practice, diagnosing fresh vertebral compression fractures often requires MRI. However, due to the scarcity of MRI resources and the high time and economic costs involved, some patients may not receive timely diagnosis and treatment. Using a deep learning model combined with X-rays for diagnostic assistance could potentially serve as an alternative to MRI. In this study, the main collection included X-ray images suspected of thoracolumbar vertebral compression fractures from the municipal shared database between December 2012 and February 2024. Deep learning models were constructed using frameworks of EfficientNet, MobileNet, and MnasNet, respectively. We conducted a preliminary evaluation of the deep learning model using the validation set. The diagnostic performance of the models was evaluated using metrics such as AUC value, accuracy, sensitivity, specificity, F1 score, precision, and ROC curve. Finally, the deep learning models were compared with evaluations from two spine surgeons of different experience levels on the control set. This study included a total of 3025 lateral X-ray images from 2224 patients. The data set was divided into a training set of 2388 cases, a validation set of 482 cases, and a control set of 155 cases. In the validation set, the three groups of DL models had accuracies of 83.0%, 82.4%, and 82.2%, respectively. The AUC values were 0.861, 0.852, and 0.865, respectively. In the control set, the accuracies of the three groups of DL models were 78.1%, 78.1%, and 80.7%, respectively, all higher than spinal surgeons and significantly higher than junior spine surgeon. This study developed deep learning models for detecting fresh vertebral compression fractures, demonstrating high accuracy.

Non-contrast CT (NCCT) is widely used in clinical practice and holds potential for large-scale atherosclerosis screening, yet its application in detecting and grading aortic atherosclerosis remains limited. To address this, we propose Aortic-AAE, an automated segmentation system based on a cascaded attention mechanism within the nnU-Net framework. The cascaded attention module enhances feature learning across complex anatomical structures, outperforming existing attention modules. Integrated preprocessing and post-processing ensure anatomical consistency and robustness across multi-center data. Trained on 435 labeled NCCT scans from three centers and validated on 388 independent cases, Aortic-AAE achieved 81.12% accuracy in aortic stenosis classification and 92.37% in Agatston scoring of calcified plaques, surpassing five state-of-the-art models. This study demonstrates the feasibility of using deep learning for accurate detection and grading of aortic atherosclerosis from NCCT, supporting improved diagnostic decisions and enhanced clinical workflows.